SCHEMBL24969043

SCHEMBL24969043

C=CCOc1cc(Br)ccc1OC

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
HPGD P15428 1/20 0.55
MEN1 O00255 1/20 0.55
HTT P42858 1/20 0.55
KMT2A Q03164 1/20 0.55
MAPK1 P28482 1/20 0.49
KDM4E B2RXH2 2/20 0.49
PDE4B Q07343 4/20 0.48
PDE4A P27815 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48
PPARG P37231 1/20 0.46
PPARD Q03181 1/20 0.46
PPARA Q07869 1/20 0.46
CYP2D6 P10635 1/20 0.43
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15758311 0.93 KDM4E (0.56) ALDH1A1HPGDMEN1HTTKMT2A
SCHEMBL4016055 0.81 ALDH1A1 (0.56) ALDH1A1HPGDMEN1HTTKMT2A
SCHEMBL21728084 0.81 HPGD (0.53) ALDH1A1HPGDMEN1HTTKMT2A
SCHEMBL23757590 0.81 GAA (0.54) ALDH1A1MEN1HTTKMT2AMAPK1
SCHEMBL30144759 0.81 GAA (0.54) ALDH1A1MEN1HTTKMT2AMAPK1
SCHEMBL8038343 0.81 KDM4E (0.50) ALDH1A1HPGDMEN1KMT2AKDM4E
SCHEMBL2322279 0.80 HPGD (0.59) ALDH1A1HPGDMEN1HTTKMT2A
SCHEMBL14392489 0.80 HPGD (0.59) ALDH1A1HPGDMEN1HTTKMT2A
SCHEMBL9491052 0.79 TRPA1 (0.59) ALDH1A1MEN1KMT2AKDM4EPDE4B
SCHEMBL5210543 0.79 HPGD (0.58) ALDH1A1HPGDMEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023009785-A1 TEAD INHIBITORS AND USES THEREOF CEDILLA THERAPEUTICS, INC. (US) 2023-02-02 WO disclosed
WO-2023009785-A1 TEAD INHIBITORS AND USES THEREOF CEDILLA THERAPEUTICS, INC. (US) 2023-02-02 WO disclosed